6160.HK
BeOne Medicines AG
1W: -4.4%
1M: -23.3%
3M: -15.3%
YTD: -21.3%
1Y: +22.9%
3Y: +0.7%
5Y: +11.6%
HK$164.00 ($20.98)
-3.30 (-1.97%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$251.3B ($32.1B)
52W Range115.8-229.4
Volume3,131,066
Avg Volume3,518,942
Beta0.52
Dividend—
Analyst Ratings
Company Info
CEOJohn V. Oyler
Employees11,000
SectorHealthcare
IndustryBiotechnology
IPO Date2018-08-08
Websitebeonemedicines.com
Aeschengraben 27
Basel, MA 4051
CH
Basel, MA 4051
CH
41 61 685 19 00
About BeOne Medicines AG
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Latest News
No recent news
Recent Insider Trades
No insider trades found